IDH1 and central nervous system cancer: Notably, a study involving 38 unprocessed samples, comprising a total of 2073 Raman spectra, demonstrated the potential of RS to differentiate between IDH-mutant (IDH-MUT) and IDH-wildtype (IDH-WT) gliomas with an accuracy and precision of 87%.